InvestorsHub Logo
Followers 16
Posts 5556
Boards Moderated 1
Alias Born 04/21/2014

Re: A deleted message

Tuesday, 05/22/2018 9:15:12 AM

Tuesday, May 22, 2018 9:15:12 AM

Post# of 113804
Learjetter, you state that adv27a was given to a private company. I'm not sure that's accurate. I believe the company who holds the patent for Adva27 is a sub of SBFM. My understanding is that Atlas was acquired to help with the chemical analysis and the generic drug production. The 10Q filed today shows they made roughly 90K in the first quarter. That is a start, but needs to be higher to cover the costs. Also, the raising of the money is not for generics, it's to progress with Adva27.

That being said, I believe management is the issue as they don't know how to run a business. Why would anyone buy shares at .02 per share when they can go to the open market and pay significantly less? Not sure Jitney and SBFM realize that to raise capital for a company in this position, you don't charge more for the shares than what the open market is demanding. I hope they get it, but I wouldn't buy any.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News